Adam Skarka

Adam Skarka

Auto-generated profile, based on publicly available information

Adam Skarka

Department of Chemistry, Faculty of Sciences, University of Hradec Kralove, Hradecká 1285, 500 03 Hradec Kralove, Czech Republic

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2012 in The Journal of Steroid Biochemistry and Molecular Biology
Verified
Journal Article
Closed access
MKMichael Kisiela
Michael Kisiela
ASAdam Skarka
Adam Skarka
BEBettina Ebert
Bettina Ebert
EMEdmund Maser
Edmund Maser

1 November 2017 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
VHVeronika Hanušová
Veronika Hanušová
KCKateřIna Caltová
KateřIna Caltová
HSHana Svobodová
Hana Svobodová
MAMartin Ambrož
Martin Ambrož
ASAdam Skarka
Adam Skarka
LSLenka Skalova
Lenka Skalova

1 August 2014 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
JHJakub Hofman
Jakub Hofman
BMBeata Malcekova
Beata Malcekova
ASAdam Skarka
Adam Skarka
ENEva Novotna
Eva Novotna
VWVladimír Wsól
Vladimír Wsól

21 August 2015 in Molecules
Verified
Journal Article
Open access
PDF file
MAMartin Ambrož
Martin Ambrož
IBIva Boušová
Iva Boušová
ASAdam Skarka
Adam Skarka
VHVeronika Hanušová
Veronika Hanušová
VKVěra Králová
Věra Králová
LSLenka Skalova
Lenka Skalova
The sesquiterpenes β-caryophyllene, β-caryophyllene oxide (CAO), α-humulene (HUM), trans-nerolidol (NER), and valencene (VAL) are substantial components of the essential oil from Myrica rubra leaves which has exhibited significant antiproliferative effects in several intestinal cancer cell lines, with CaCo-2 cells being the most sensitive. The present study was designed to evaluate the effects of these sesquiterpenes on the efficacy and toxicity of the anticancer drug doxorubicin (DOX) in CaCo-2 cancer cells and in primary culture of rat hepatocytes. Our results showed that HUM, NER, VAL and CAO inhibited proliferation of CaCo-2 cancer cells but they did not affect the viability of hepatocytes. CAO, NER and VAL synergistically potentiated the efficacy of DOX in cancer cells killing. All sesquiterpenes exhibited the ability to selectively increase DOX accumulation in cancer cells and did not affect DOX concentration in hepatocytes. Additionally, CAO and VAL were able to increase the pro-oxidative effect of DOX in CaCo-2 cells. Moreover, CAO mildly ameliorated DOX toxicity in hepatocytes. Based on all results, CAO seems to be the most promising compound for further testing.

1 November 2018 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
TZTamara Zorbaz
Tamara Zorbaz
DMDávid Maliňák
Dávid Maliňák
NMNikola Maraković
Nikola Maraković
NHNikolina Maček Hrvat
Nikolina Maček Hrvat
AZAntonio Zandona
Antonio Zandona
KMKamil Musilek
Kamil Musilek

20 June 2017 in Molecules
Verified
Journal Article
Open access
PDF file
MAMartin Ambrož
Martin Ambrož
PMPetra Matouskova
Petra Matouskova
ASAdam Skarka
Adam Skarka
MZMartina Zajdlová
Martina Zajdlová
KŽKateřina Žáková
Kateřina Žáková
LSLenka Skalova
Lenka Skalova
β-caryophyllene oxide (CAO), α-humulene (HUM), trans-nerolidol (NER) and valencene (VAL) are constituents of the essential oil of Myrica rubra (MEO), which has significant antiproliferative effect in various cancer cell lines. In the present study, we compared the antiproliferative effect of these sesquiterpenes alone and in combination with the cytostatic drug doxorubicin (DOX) in cancer cell lines with different sensitivity to DOX. Two ovarian cancer cell lines (sensitive A2780 and partly resistant SKOV3) and two lymphoblast cancer cell lines (sensitive CCRF/CEM and completely resistant CEM/ADR) were used. The observed effects varied among sesquiterpenes and also differed in individual cell lines, with only VAL being effective in all the cell lines. A strong synergism of DOX with NER was found in the A2780 cells, while DOX acted synergistically with HUM and CAO in the SKOV3 cells. In the CCRF/CEM cells, a synergism of DOX with CAO and NER was observed. In resistant CEM/ADR cells, sesquiterpenes did not increase DOX efficacy, although they significantly increased accumulation of DOX (up to 10-times) and rhodamine-123 (substrate of efflux transporter ABCB1) within cancer cells. In conclusion, the tested sesquiterpenes were able to improve DOX efficacy in the sensitive and partly resistant cancer cells, but not in cells completely resistant to DOX.